Cefpodoxime: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk (New page: {{subpages}} {{Chem infobox |align=right |image=center|thumb|250px |width=250px |molname=cefpodoxime |synonyms= |molformula= C<sub>15</sub>H<sub>17</sub>N<sub>5<...) |
imported>David E. Volk |
||
| Line 18: | Line 18: | ||
== Mechanism of action == | == Mechanism of action == | ||
Like other [[cephalosporin]]s and [[peniciillin]]s, cefpodoxime inhibits the proper formation of bacterial cells walls in the last stage of cell wall synthesis. Because cefpodoxime is stable against many beta-[[lactamase]]s, many organisms that are resistant to penicillins and cephalosporins, due to their beta-lactamase production, may be susceptible to cefpodoxime. Some extended-spectrum beta-lactamases may inactivate cefpodoxime. | |||
== Brand names == | == Brand names == | ||
Revision as of 11:40, 14 July 2008
|
| |||||||
| cefpodoxime | |||||||
| |||||||
| Uses: | antibiotic drug | ||||||
| Properties: | cephalosporin beta-lactam | ||||||
| Hazards: | |||||||
| |||||||
Cefpodoxime is a third-generation cephalosporin-based antibiotic useful against most Gram-postitive and Gram-negative bacteria.
Mechanism of action
Like other cephalosporins and peniciillins, cefpodoxime inhibits the proper formation of bacterial cells walls in the last stage of cell wall synthesis. Because cefpodoxime is stable against many beta-lactamases, many organisms that are resistant to penicillins and cephalosporins, due to their beta-lactamase production, may be susceptible to cefpodoxime. Some extended-spectrum beta-lactamases may inactivate cefpodoxime.
Brand names
- Vantin®
- Banan®
- Doxef®
- Orelox®
- Otreon®
- Podomexef®
The most up-to-date information about Cefpodoxime and other drugs can be found at the following sites.
- Cefpodoxime - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Cefpodoxime - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Cefpodoxime - Detailed information from DrugBank.